p53 in lymphomas of mucosal-associated lymphoid tissues

V Levy1, C Miller, H P Koeffler

  • 1Department of Pathology and Internal Medicine, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.

Insights

Mucosal-associated lymphoid tissue (MALT) lymphomas lack p53 mutations, unlike splenic marginal zone lymphomas. This suggests different lymphomagenesis mechanisms for MALT lymphomas, though some express low p53 protein levels.

Area of Science:

  • Oncology
  • Hematology
  • Molecular Biology

Background:

  • Mucosal-associated lymphoid tissue (MALT) lymphomas are a distinct group of B-cell lymphomas.
  • Their cellular origin is debated, with potential links to marginal zone lymphocytes.
  • Marginal zone lymphomas exhibit frequent p53 mutations, prompting investigation into MALT lymphomas.

Purpose of the Study:

  • To investigate the presence of p53 mutations in MALT lymphomas.
  • To compare p53 mutation status between MALT lymphomas and marginal zone lymphomas.
  • To assess p53 gene protein product expression in MALT lymphoma tissues.

Main Methods:

  • Polymerase chain reaction and single-strand conformational polymorphism (PCR-SSCP) analysis of exons 4-8 of the p53 gene.
  • Immunohistochemical examination for p53 protein expression.
  • Analysis of MALT lymphoma specimens from gastric, parotid, and small bowel tissues.

Main Results:

  • No p53 mutations were detected in any of the evaluated MALT lymphoma specimens.
  • p53 gene protein product was expressed in the nuclei of neoplastic cells in 3 out of 15 MALT lymphoma cases, at low levels (<10%).
  • These findings contrast with the high rate of p53 mutations observed in splenic marginal zone lymphomas.

Conclusions:

  • Low-grade MALT lymphomas appear to differ from marginal zone lymphomas due to the absence of p53 point mutations.
  • The distinct p53 mutation profile suggests alternative pathways in the lymphomagenesis of MALT lymphomas.
  • While lacking mutations, some MALT lymphomas show low-level p53 protein expression, indicating potential roles for p53 independent of mutation.